Ideaya Biosciences Inc

NASDAQ:IDYA   4:00:00 PM EDT
43.88
+0.57 (+1.32%)
4:20:00 PM EDT: $43.88 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)3.27B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$5.43 Million
Adjusted EPS-$0.51
See more estimates
10-Day MA$43.76
50-Day MA$44.34
200-Day MA$32.08
See more pivots

Ideaya Biosciences Inc Stock, NASDAQ:IDYA

7000 Shoreline Court, Suite 350, South San Francisco, California 94080-1945
United States of America
Phone: +1.650.443.6209
Number of Employees: 124

Description

IDEAYA Biosciences, Inc. engages in the research and development of oncology-focused precision medicine. The firm focuses on the targeted therapeutics for patients selected using molecular diagnostics. Its product candidate, IDE196, is a protein kinase C inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations. The company was founded by Yujiro S. Hata and Jeffrey Hager in June 2015 and is headquartered in South San Francisco, CA.